Cavidi is a Swedish biotechnology company specialising in ultra-sensitive biomarker detection. Their innovative reagent, Exazym®™, enhances standard ELISA by attomole-level detection of low-abundance biomarkers with minimal adjustments and no need for new equipment. Originally founded in 1984 by virologists from Uppsala University, Cavidi commits to simplifying access to high-precision diagnostics. By providing their innovative reagents and their proprietary BOLD technology we support you in achieving new limits of detection across a broad range of applications